Clinical comparison of anxiolytic drug therapy.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000654:Amobarbital / Q000627:therapeutic use*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety; D001463:Barbiturates / Q000008:administration & dosage / Q000009:adverse effects; D002214:Capsules; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008472:Medazepam / Q000627:therapeutic use; D008875:Middle Aged; D010352:Patient Dropouts; D010919:Placebos; D011581:Psychological Tests; D012008:Recurrence; D012647:Self-Assessment; D013997:Time Factors
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D002214:Capsules; D010919:Placebos; D002707:Chlordiazepoxide; D000654:Amobarbital; D008472:Medazepam; D003975:Diazepam